PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Lipodystrophy”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,225 records · Page 68Linked to original sources

Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy.

Patients treated with insulin can develop a variety of adverse cutaneous and subcutaneous reactions localized at sites of insulin injection. The reported frequency, severity, and type of skin reactions to insulin are varied, as are the theories relating to their etiology and recommendations for treatment. In this review, several types of localized skin reactions to insulin injection will be described. Particular attention will be devoted to insulin lipoatrophy and skin reactions in patients using mechanical devices for continuous subcutaneous insulin infusion. Recent advances in diabetes care have made insulin-induced lipoatrophy a preventable and treatable disorder. However, localized skin reactions are emerging as a potential problem among users of insulin infusion pumps.

Drug Eruptions↗

Insulin-induced hypertrophic lipodystrophy.

Localized asymptomatic soft tissue swellings developed in a 20-year-old woman, Type I juvenile-onset diabetic, at the site of repeated insulin injections. Histopathologic examination of specimens from these lesions in three patients showed chronic inflammatory changes and exogenous foreign material that was thought to be silicon. Lipodystrophic changes associated with insulin therapy are briefly reviewed.

Adult↗

[Premature aging syndromes with special reference to lipodystrophy (a case report)].

The authors survey the modern classification of progeria and report on a 12-year old girl suffering from lipodystrophia totalis and diabetes mellitus (Lawrence-Seip-syndrome). The girl developed sclerodermiform changes at the age of one year, at her 10th year acanthosis nigricans, xanthoma tuberosum Fredrickson hyperlipoproteinaemie IV, later II/B type and finally at an age of 11 1/2 year diabetes mellitus.

Child↗